InflaRx N.V.

US$1.30As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IFRXHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (26.83%)
Div yield —
ROE (30.95%)
Biotechnology
Beta (5Y) 2.42
PE TTM —
TSR TTM (10.62%)
Mkt cap US$192.3M
ROIC (21.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.44
10.49%
89.45%
Sell 3|1|7|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
11.57%
2.13%
7.68%
7.32%
Revenue€M
8.367
8.371
8.289
8.522
0.77%
(2.02%)
(0.68%)
1.24%
Peers (US$192.3M)
Cap (US$)
PE
279.8M
—
134.3M
—
192.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.024
0.769
0.521
EBIT/Intx
1.731
0.499
0.461
Own earn%
8.49
124.65
118.44
Sh yield%
29.93
25.12
26.79
Owners
Insiders/Inst%
7.52
70.26
Short interest%
5.38
SBC / revenue%
2.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–11
$1 testx
—
Incr. ROIC%
4